Rochester General Hospital — Rochester, New York

Rochester General Hospital is a clinical research site located in Rochester, New York, United States 14621.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Rochester General Hospital has participated in 115 clinical trials with 39 currently active.

Therapeutic areas: Stroke, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Sponsors: Boston Scientific Corporation, National Cancer Institute (NCI), Abbott Medical Devices.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester General Hospital?

Rochester General Hospital has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester General Hospital conducted?

Rochester General Hospital has 115 clinical trials on record, with 39 currently active. Their work covers Stroke, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Is Rochester General Hospital accredited by Crixeo Health?

Yes — Rochester General Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rochester General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.